Literature DB >> 7033435

Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis.

G Biesecker, S Katz, D Koffler.   

Abstract

The membrane attack complex (MAC) of the complement system was localized in both glomeruli and peritubular regions of 22 kidneys manifesting systemic lupus erythematosus (SLE) nephritis. A similar distribution was observed for immune complex markers (IgG, Clq, and C3) and MAC in glomeruli, although the deposits of MAC were more discrete and showed lesser immunofluorescence staining intensity compared with immunoglobulins and complement components. In contrast, peritubular immune complexes were present in only 7 out of 22 kidneys, involved comparatively small clusters of tubules, exhibited weaker immunofluorescence staining than MAC, and failed to correlate with interstitial foci of inflammation. Granular or irregular, linear aggregates of the MAC were observed at the periphery of larger groups of tubules contiguous to areas of interstitial inflammation. Comparable amounts of IgG, Clq, C3, and MAC were present in blood vessel walls in areas of fibrinoid necrosis. These data suggest that the MAC is a direct mediator of tissue injury occurring in renal glomeruli, tubules, and blood vessels. The discordance between immune complexes and MAC localized in the peritubular region, but not in glomeruli or blood vessels, raises the possibility that both immune complexes and nonimmune agents, such as bacterial antigens, may activate the classical or alternative complement pathways and thereby play a role in the pathogenesis of tubulointerstitial lesions of SLE nephritis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7033435      PMCID: PMC2186538          DOI: 10.1084/jem.154.6.1779

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  36 in total

1.  Immunopathologic study of an autoimmune tubular and interstitial renal disease in brown Norway rats.

Authors:  T Sugisaki; J Klassen; F Milgrom; G A Andres; R T McCluskey
Journal:  Lab Invest       Date:  1973-06       Impact factor: 5.662

Review 2.  Immune complex systems in the nephritis of systemic lupus erythematosus.

Authors:  V Agnello; D Koffler; H G Kunkel
Journal:  Kidney Int       Date:  1973-02       Impact factor: 10.612

3.  Variable patterns of immunoglobulin and complement deposition in the kidneys of patients with systemic lupus erythematosus.

Authors:  D Koffler; V Agnello; R I Carr; H G Kunkel
Journal:  Am J Pathol       Date:  1969-09       Impact factor: 4.307

4.  Immunologic factors and clinical activity in systemic lupus erythematosus.

Authors:  P H Schur; J Sandson
Journal:  N Engl J Med       Date:  1968-03-07       Impact factor: 91.245

5.  Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.

Authors:  E M Tan; P H Schur; R I Carr; H G Kunkel
Journal:  J Clin Invest       Date:  1966-11       Impact factor: 14.808

6.  Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus.

Authors:  D Koffler; V Agnello; H G Kimkel
Journal:  Am J Pathol       Date:  1974-01       Impact factor: 4.307

7.  Localization of fluorescein-labeled antinucleoside antibodies in glomeruli of patients with active systemic lupus erythematosus nephritis.

Authors:  G A Andres; L Accinni; S M Beiser; C L Christian; G A Cinotti; B F Erlanger; K C Hsu; B C Seegal
Journal:  J Clin Invest       Date:  1970-11       Impact factor: 14.808

8.  PATHOGENIC FACTORS IN VASULAR LESIONS OF EXPERIMENTAL SERUM SICKNESS.

Authors:  W T KNIKER; C G COCHRANE
Journal:  J Exp Med       Date:  1965-07-01       Impact factor: 14.307

9.  Immunological studies concerning the nephritis of systemic lupus erythematosus.

Authors:  D Koffler; P H Schur; H G Kunkel
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

10.  Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease.

Authors:  D Koffler; R Carr; V Agnello; R Thoburn; H G Kunkel
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

View more
  40 in total

1.  Detection of the terminal fluid-phase complement complex, SC5b-9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor.

Authors:  G Triolo; E Giardina; D Casiglia; G Scarantino; G D Bompiani
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

Review 2.  Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?

Authors:  M Peakman; G Senaldi; D Vergani
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

Review 3.  Antiendothelial cell antibodies (AECA) in systemic lupus erythematosus (SLE).

Authors:  D D'Cruz; M Khamashta; G Hughes
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

4.  Technical improvements in the immunoperoxidase study of renal biopsy specimens.

Authors:  A J Howie; J Gregory; R A Thompson; M A Adkins; A J Niblett
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

Review 5.  Lupus nephritis: the evolving role of novel therapeutics.

Authors:  Brad H Rovin; Samir V Parikh
Journal:  Am J Kidney Dis       Date:  2014-01-07       Impact factor: 8.860

6.  N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosus.

Authors:  Tang-Dong Liao; Pablo Nakagawa; Branislava Janic; Martin D'Ambrosio; Morel E Worou; Edward L Peterson; Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2015-03-04

7.  Immunolocalization of complement component C9 on necrotic and non-necrotic muscle fibres in myositis using monoclonal antibodies: a primary role of complement in autoimmune cell damage.

Authors:  B P Morgan; C A Sewry; K Siddle; J P Luzio; A K Campbell
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

8.  Immunohistochemical detection of the terminal C5b-9 complement complex in children with glomerular diseases.

Authors:  H G Rus; F Niculescu; M Nanulescu; A Cristea; P Florescu
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

9.  Quantitative evaluation of the terminal C5b-9 complement complex by ELISA in human atherosclerotic arteries.

Authors:  F Niculescu; F Hugo; H G Rus; R Vlaicu; S Bhakdi
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

10.  Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies.

Authors:  C L Koski; M E Sanders; P T Swoveland; T J Lawley; M L Shin; M M Frank; K A Joiner
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.